Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 11/20 | 0.34 |
| ▸ | RXRG | P48443 | 8/20 | 0.34 |
| ▸ | RXRB | P28702 | 7/20 | 0.34 |
| ▸ | RARA | P10276 | 4/20 | 0.34 |
| ▸ | RARG | P13631 | 4/20 | 0.33 |
| ▸ | RARB | P10826 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29401105 | 0.78 | RXRA (0.41) | RXRARXRGRXRBRARARARG | |
| SCHEMBL5009416 | 0.78 | RXRA (0.41) | RXRARXRGRXRBRARARARG | |
| Lithium SCHEMBL29602414 | 0.76 | RXRA (0.40) | RXRARXRGRXRBRARARARG | |
| Hydrochloric Acid SCHEMBL15653289 | 0.75 | RXRA (0.33) | RXRARXRGRXRBRARARARG | |
| SCHEMBL6910159 | 0.75 | RXRA (0.33) | RXRARXRGRXRBRARARARG | |
| SCHEMBL4564960 | 0.71 | RXRA (0.33) | RXRARXRGRXRBRARARARG | |
| SCHEMBL29969818 | 0.71 | RXRA (0.33) | RXRARXRGRXRBRARARARG | |
| SCHEMBL4970470 | 0.70 | RXRA (0.31) | RXRARXRGRXRBRARARARG | |
| SCHEMBL29969300 | 0.67 | — | — | |
| SCHEMBL11599145 | 0.67 | RXRA (0.42) | RXRARXRGRXRBRARARARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7601666-B2 | Provide polymers having high molecular weight as well as good crystallinity preferably prepared at higher temperatures and productivities than otherwise possible | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2009-10-13 | — | — | US | disclosed |
| EP-1765841-B1 | OLEFIN POLYMERIZATION CATALYST SYSTEM AND PROCESS FOR USE THEREOF | EXXONMOBIL CHEM PATENTS INC (US) | 2008-10-08 | — | — | EP | disclosed |
| CN-101124235-A | Olefin polymerization catalyst system and method of using same | EXXONMOBIL CHEM PATENTS INC (US) | 2008-02-13 | — | — | CN | disclosed |
| US-20060009595-A1 | Olefin polymerization catalyst system and process for use thereof | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009595-A1 | Olefin polymerization catalyst system and process for use thereof | OR10J3, CHRM2, CHRM1 | RXRA 1309/4885RXRG 1375/4885RXRB 1474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.